(2154–2178) Systemic Sclerosis and Related Disorders – Clinical Poster III

Monday, November 14, 2022

1:00 PM – 3:00 PM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

1:00 PM – 3:00 PM Eastern Time

An Exploratory Phosphoproteomic and Immunohistochemical Analysis of Receptor Tyrosine Kinases and Downstream Signaling Pathways in Systemic Sclerosis Skin
Abstract Poster Presenter: Elizabeth Bundschuh, BA – Yale University
1:00 PM – 3:00 PM Eastern Time

Sclerodermoid Reaction Following Immune Checkpoint Inhibitor Therapy: A Case Series from MD Anderson Cancer Center
Abstract Poster Presenter: Julia Chernis, MD – McGovern Medical School at the UTHSC Houston
1:00 PM – 3:00 PM Eastern Time

Clinical Benefits of Lung Transplantation in Systemic Sclerosis-related Interstitial Lung Disease; A Single-Center Retrospective Study
Abstract Poster Presenter: Yoichi Nakayama, MD – Kyoto University
1:00 PM – 3:00 PM Eastern Time

Evaluation of Functional Disability over Time in the Leiden Systemic Sclerosis (CCISS) Cohort
Abstract Poster Presenter: Sophie Liem, MD – LUMC
1:00 PM – 3:00 PM Eastern Time

A Decade of Caring for SSc Patients: Do Outcomes Improve? Data from the Leiden CCISS Cohort
Abstract Poster Presenter: Sophie Liem, MD – LUMC
1:00 PM – 3:00 PM Eastern Time

Gastroesophageal Reflux Disease in an Australian Scleroderma Cohort - Associations and Effect of Treatment
Abstract Poster Presenter: Alannah Quinlivan, MBBS – St Vincent's Hospital Melbourne
1:00 PM – 3:00 PM Eastern Time

The Role of CCL21 in Serum Samples from Systemic Sclerosis Patients
Abstract Poster Presenter: Henriette Didriksen, MS – Oslo University Hospital
1:00 PM – 3:00 PM Eastern Time

Alterations of Nutritional Status of Scleroderma Patients and Associations with Disease-specific Features
Abstract Poster Presenter: Sabína Oreská, MD – Institute of Rheumatology
1:00 PM – 3:00 PM Eastern Time

Systemic Sclerosis in Alaska Native/American Indian People in Alaska
Abstract Poster Presenter: Vivek Mehta, MBBS – Alaska Native Tribal Health Consortium
1:00 PM – 3:00 PM Eastern Time

Lipid Profile in Scleroderma Patients and the Associations of Its Changes with Disease-specific Features
Abstract Poster Presenter: Sabína Oreská, MD – Institute of Rheumatology
1:00 PM – 3:00 PM Eastern Time

Profibrotic Alveolar Macrophages as a Potential Biomarker in Systemic Sclerosis-associated Interstitial Lung Disease
Abstract Poster Presenter: Monique Hinchcliff, MD, MS – Yale School of Medicine
1:00 PM – 3:00 PM Eastern Time

Patients with Systemic Sclerosis Have Impaired Forced Vital Capacity, Even in the Absence of Interstitial Lung Disease
Abstract Poster Presenter: Havard Fretheim, MD, PhD – Oslo University Hospital
1:00 PM – 3:00 PM Eastern Time

Inflammatory Arthritis in an Australian Scleroderma Cohort – Patient Characteristics, Associations and Treatments
Abstract Poster Presenter: Eric Schwender, BSc – Royal College of Surgeons
1:00 PM – 3:00 PM Eastern Time

Autoantibodies in Patients with Early Systemic Sclerosis in the Collaborative National Quality and Efficacy Registry
Abstract Poster Presenter: Alyssa Bosso, MD – Medstar Georgetown University Hospital
1:00 PM – 3:00 PM Eastern Time

A Novel Pharmaco-Interventional Approach for the Treatment of Refractory Digital Ischemia in Systemic Sclerosis – Percutaneous Revascularization Combined with Intravenous Vasodilatory Therapy
Abstract Poster Presenter: Lily Romero Karam, MD – University of Texas Health Science Center Houston
1:00 PM – 3:00 PM Eastern Time

Cardiac Rhythm and Conduction Abnormalities in Systemic Sclerosis-meta-analysis
Abstract Poster Presenter: Drashti Antala, MBBS – Ascension Saint Francis Internal Medicine residency program
1:00 PM – 3:00 PM Eastern Time

Validation of Ranked Composite Important Difference (RCID) Score in Early Diffuse Cutaneous Systemic Sclerosis
Abstract Poster Presenter: Francesco Del Galdo, MD, PhD – University of Leeds
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Pulmonary Function in Patients Diagnosed of Early Systemic Sclerosis: 10 Years-Experience
Abstract Poster Presenter: Samuel Leal, MD – Hospital La Fe
1:00 PM – 3:00 PM Eastern Time

Rheumatology Telemedicine Consults: Impact of Demographic Variability on Patient Perception in Systemic Sclerosis versus Rheumatoid Arthritis Pts
Abstract Poster Presenter: Yossra atef Suliman, MD – Assiut University Hospital, Assiut Egypt
1:00 PM – 3:00 PM Eastern Time

Influence of Immunosuppressive Therapy on Gastrointestinal Symptoms in Patients with Systemic Sclerosis
Abstract Poster Presenter: Carina Mihai, MD – Universitatsspital Zürich
1:00 PM – 3:00 PM Eastern Time

Evaluation of the Distribution of Haemodynamic Parameters and Prognostic Impact in a Cohort of Patients with Systemic Sclerosis
Abstract Poster Presenter: Zoe Brown, MBBS, FRACP – The University of Melbourne
1:00 PM – 3:00 PM Eastern Time

Novel Tissue Turnover Blood Markers Are Associated with Pulmonary Arterial Hypertension and NYHA Stages in Patients with Systemic Sclerosis
Abstract Poster Presenter: Signe Holm Nielsen, PhD – Nordic Bioscience
1:00 PM – 3:00 PM Eastern Time

Familial Clustering of Systemic Sclerosis, Autoimmunity, and Cancer History
Abstract Poster Presenter: Timothy Niewold, MD, FACR – Hospital for Special Surgery
1:00 PM – 3:00 PM Eastern Time

BNT162b2 mRNA Vaccine Against Covid 19, Humoral Response, Safety and Efficacy in Scleroderma Patients
Abstract Poster Presenter: Alexandra Balbir-Gurman, MD – Rheumatology Institute, Rambam Health Care Campus and Rappaport Faculty of |Medicine, Technion